Q6M130 AF NFT

Glutamyl-tRNA reductase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeic5oal57un36kpchxgslu2gs7oc6l2kubemelwa3mjwt3f6k3mege/metadata.json
IPFS of structure file: 
bafybeigyniipqjirqmzdluwecnvebgtfwncrxmzjgov7cugx5rxki4ih4y/AF-Q6M130-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x5Ed6BFcdacb6badB27582f1166F4aAdB839FC5D7
First NFT owner address (bech32): 
genesis1tmttlndvk6adkf6c9ugkda92mwpel3whllayp0
Current NFT ID #166716 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
166716
Accession (UniProt):
Q6M130
Name::
Glutamyl-tRNA reductase
Experimental Method:
Predicted structure
Sequence source:
METHANOCOCCUS MARIPALUDIS (STRAIN S2 / LL)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q6M130 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q6M130|HEM1_METMP Glutamyl-tRNA reductase OS=Methanococcus maripaludis (strain S2 / LL) OX=267377 GN=hemA PE=3 SV=1 MLVVRADYKKYPIPVLEKMRIDEDEFYKKYDACVVVQTCNRIEAYFDTEVNSDLNCILNDFSGFDILKGKNATFHFLKVSCGMDSMILGENQILGQIKTSFQKARELKKTSRYLDSVFLKAIHVGQRARTETKINEGSVSIGSAAVELAEKNFGLANKNVLLIGAGEIGTLVAKALMEKHIKAVIVANRTYERAETLAKELKGMAVHFDKLKEAINFSDVIICATSSPHYILKKEDLIDVGNKIIIDIANPRDVDDAVREFENINLYTIDDLRNISDKNLQKRIEEVPAVEKIIDEEYDVLMKQIEKINVEEVLKDFNNYIEEIRTKELEKAIKLSKTKNPEEIMENFSKAFAKRITHDFVSYSINTSKEDLMNSAWWKNGK